Associated Papers
48-Year clinical experience and genetic analysis of pediatric primary hyperparathyroidism from a single center in China.
Chen Y et al.
Journal of Endocrinological Investigation, 2025
Multi-locus inherited neoplasia alleles syndromes in cancer: implications for clinical practice.
Yuen J et al.
European Journal of Human Genetics : Ejhg, 2025
Genetic Landscape and Clinical Manifestations of Multiple Endocrine Neoplasia Type 1 in a Korean Cohort: A Multicenter Retrospective Analysis.
Kim B et al.
Endocrinology and Metabolism (seoul, Korea), 2024
Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P et al.
Virchows Archiv : an International Journal of Pathology, 2023
Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.
Simonds WF
Frontiers in Endocrinology, 2023
Clinical aspects of multiple endocrine neoplasia type 1.
Al-Salameh A et al.
Nature Reviews. Endocrinology, 2021
[Multiple Endocrine Neoplasia].
Uchino S et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy, 2019
Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing.
Carvalho RA et al.
European Journal of Endocrinology, 2018
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
Marini F et al.
Endocrine, 2018
Children with MEN1 gene mutations may present first (and at a young age) with Cushing disease.
Makri A et al.
Clinical Endocrinology, 2018
Uncovering the heterogeneous genetic variations in two insulin-expressing tumors in a patient with MEN1.
Wang Z et al.
Oncology Letters, 2018
Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome.
Mamedova E et al.
Endocrine Connections, 2017
Novel association of MEN1 gene mutations with parathyroid carcinoma.
Cinque L et al.
Oncology Letters, 2017
Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.
Bonnavion R et al.
The Journal of Pathology, 2017
Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.
Falchetti A
F1000research, 2017
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.
Pardi E et al.
Plos One, 2017
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).
Giusti F et al.
Endocrine, 2016
[TYPE 1 MULTIPLE ENDOCRINE NEOPLASIA SYNDROME AND FAMILIAL ISOLATED HYPERPARATHYROIDISM].
Mamedova EO et al.
Klinicheskaia Meditsina, 2015
Genetic and epigenetic analysis in korean patients with multiple endocrine neoplasia type 1.
Chung YJ et al.
Endocrinology and Metabolism (seoul, Korea), 2014
p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?
Nozières C et al.
Annales D'endocrinologie, 2014
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Molecular and Cellular Endocrinology, 2014
MEN1 gene analysis in patients with primary hyperparathyroidism: 10-year experience of a single institution for thyroid and parathyroid care in Japan.
Kihara M et al.
Endocrine Journal, 2009
Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Hussein N et al.
Endocrine-related Cancer, 2008
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.
Lemos MC et al.
Human Mutation, 2008
Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
Hussein N et al.
European Journal of Cancer (oxford, England : 1990), 2007
Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
Lim LC et al.
Journal of Internal Medicine, 2006
Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
Ellard S et al.
Clinical Endocrinology, 2005
Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
Klein RD et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2005
Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese.
Tso AW et al.
Clinical Endocrinology, 2003
Functional studies of the MEN1 gene.
Chandrasekharappa SC et al.
Journal of Internal Medicine, 2003
Efficient mutation detection in MEN1 gene using a combination of single-strand conformation polymorphism (MDGA) and heteroduplex analysis.
Crépin M et al.
Electrophoresis, 2003
Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
Guo SS et al.
World Journal of Surgery, 2002
Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B et al.
The Journal of Clinical Endocrinology and Metabolism, 2002
Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Guo SS et al.
Molecular Endocrinology (baltimore, Md.), 2001
Tumor suppressor loss in pituitary tumors.
Alexander JM
Brain Pathology (zurich, Switzerland), 2001
10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods.
Clerici T et al.
Swiss Medical Weekly, 2001
The MEN1 gene and associated diseases: an update.
Tsukada T et al.
Endocrine Pathology, 2001
Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism.
Miedlich S et al.
European Journal of Endocrinology, 2000
Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding.
Roijers JF et al.
European Journal of Clinical Investigation, 2000
Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues.
Wautot V et al.
International Journal of Cancer, 2000
MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1.
Morelli A et al.
European Journal of Endocrinology, 2000
Multiple endocrine neoplasia type 1.
Pannett AA et al.
Endocrine-related Cancer, 1999
Multiple endocrine neoplasia type 1: clinical and genetic topics.
Marx S et al.
Annals of Internal Medicine, 1998
Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders.
Giraud S et al.
American Journal of Human Genetics, 1998
Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families.
Agarwal SK et al.
Human Mutation, 1998
A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation.
Giraud S et al.
The Journal of Clinical Endocrinology and Metabolism, 1997
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.
Lemmens I et al.
Human Molecular Genetics, 1997